Skip to main content
. Author manuscript; available in PMC: 2007 Nov 14.
Published in final edited form as: Oncogene. 2007 Jan 22;26(30):4329–4335. doi: 10.1038/sj.onc.1210226

Figure 2.

Figure 2

Disruption of the Arf-Mdm2-p53 pathway in Eμ-Myc lymphomas. In Dmp1+/− and Dmp1−/− Eμ-Myc lymphomas, there is a striking reduction in the frequencies of p53 mutations and Arf deletions. This suggests that Dmp1 is a regulator of the Arf-p53 pathway in vivo.